For example, human glypican 3 (GPC3) is upregulated in most hepatocarcinoma and indicative of differentiation grade, but is downregulated in some non-liver tumors including ovarian or breast tumors (Kaseb et al., 2016). Here, GPC3 is linked to breast neoplasm.